Dose prescription and reporting in stereotactic radiosurgery: A single institutional study
Stereotactic body radiotherapy and stereotactic radiosurgery are advanced radiotherapy techniques used to treat a variety of malignancies with high precision. However, there is significant variability in dose prescription and delivery, which may impact treatment consistency and efficacy. This work presents an analysis of retrospective dosimetric data collected from 300 stereotactic body radiotherapy/stereotactic radiosurgery (SBRT/SRS) clinical treatment plans. The study evaluated the dosimetric variability across different disease sites, including lung, brain, prostate, pelvis, liver, and bone, as well as among individual treatment planning strategies. Parameters analyzed included D0.1cc, D50, D95, D99, homogeneity index, and conformity index. The results showed that, despite variations in tumor types and planning approaches, a standardized protocol at our institution helped minimize dosimetric variability. These data may facilitate interinstitutional comparisons and help to enrich the SBRT/SRS data pool for treatment standardization.
- Das IJ, Yadav P, Andersen AD, et al. Dose prescription and reporting in stereotactic body radiotherapy: A multi-institutional study. Radiother Oncol. 2023;182:109571. doi: 10.1016/j.radonc.2023.109571
- Schiff PB. Dose dissonance in radiation oncology: Consensus needed when prescribing dose in radiation therapy. Pract Radiat Oncol. 2017;7(6):e579-e580. doi: 10.1016/j.prro.2017.04.018
- Moustakis C, Blanck O, Ebrahimi F, et al. Time for standardization of SBRT planning through large scale clinical data and guideline-based approaches. Zeit für eine Standardisierung der SBRT-Planung mithilfe großer klinischer Datenmengen und leitlinienbasierter Ansätze. Strahlenther Onkol. 2017;193(12):1068-1069. doi: 10.1007/s00066-017-1216-8
- Moustakis C, Blanck O, Ebrahimi Tazehmahalleh F, et al. Planning benchmark study for SBRT of early stage NSCLC: Results of the DEGRO Working Group Stereotactic Radiotherapy. Planvergleichsstudie bei der SBRT des NSCLC im Frühstadium: Ergebnisse der DEGRO AG Stereotaxie. Strahlenther Onkol. 2017;193(10):780-790. doi: 10.1007/s00066-017-1151-8
- Eaton DJ, Naismith OF, Henry AM. Need for consensus when prescribing stereotactic body radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2015;91(1) :239-241. doi: 10.1016/j.ijrobp.2014.09.025
- ICRU Report 91: Prescribing, Recording, and reporting of Stereotactic Treatments with Small Photon Beams; 2017.
- Guckenberger M, Andratschke N, Dieckmann K, et al. ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. Radiother Oncol. 2017;124(1):11-17. doi: 10.1016/j.radonc.2017.05.012
- Moustakis C, Blanck O, Chan MKH, et al. Planning benchmark study for stereotactic body radiation therapy of liver metastases: Results of the DEGRO/DGMP working group on stereotactic radiation therapy and radiosurgery. Int J Radiat Oncol Biol Phys. 2022;113(1):214-227. doi: 10.1016/j.ijrobp.2022.01.008
- ICRU Report 83: Prescribing, Recording, and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT); 2010.
- Patel G, Mandal A, Choudhary S, Mishra R, Shende R. Plan evaluation indices: A journey of evolution. Rep Pract Oncol Radiother. 2020;25(3):336-344. doi: 10.1016/j.rpor.2020.03.002
- Akbari F, Taghizadeh S, Pearson D. A retrospective study to establish recommendations for plan quality metrics in Lung SBRT. Med Dosim. 2022;47(2):111-116. doi: 10.1016/j.meddos.2021.10.001
- Lacornerie T, Lisbona A, Mirabel X, Lartigau E, Reynaert N. GTV-based prescription in SBRT for lung lesions using advanced dose calculation algorithms. Radiat Oncol. 2014;9:223. doi: 10.1186/s13014-014-0223-5
- Spatola C, Milazzotto RM, Tocco A, et al. Metachronous NSCLC in previously irradiated patients: Is re-irradiation with SBRT a good option as definitive treatment? J Radiother Pract. 2020;19(3):215-218. doi: 10.1017/S1460396919000773
- Pontoriero A, Critelli P, Bosurgi A, et al. Recurrent gynecological tumors in previously irradiated patients. Does re-irradiation with stereotactic body radiotherapy have a role? A systematic review. Clin Exp Obstet Gynecol. 2023;50(6):134. doi: 10.31083/j.ceog5006134